Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801

This study has been completed.
Information provided by (Responsible Party):
Nanotherapeutics, Inc. Identifier:
First received: May 19, 2012
Last updated: October 7, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)